Bank of New York Mellon’s Exagen XGN Stock Holding History

Bank of New York Mellon’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.4K	Hold	20,938	–	–	﹤0.01%	4199
2026 Q1	$62.8K	Sell	20,938 -14,447	-41%	-$55.9K	﹤0.01%	4132
2025 Q4	$215K	Buy	35,385 +23,870	+207%	+$217K	﹤0.01%	3995
2025 Q3	$127K	Buy	+11,515	New	+$102K	﹤0.01%	4082
2022 Q2	–	Sell	-25,917	Closed	-$208K	–	4710
2022 Q1	$208K	Sell	25,917 -479	-2%	-$4.13K	﹤0.01%	4217
2021 Q4	$307K	Sell	26,396 -5,608	-18%	-$65.7K	﹤0.01%	4083
2021 Q3	$435K	Buy	32,004 +4,265	+15%	+$56.7K	﹤0.01%	3885
2021 Q2	$416K	Buy	27,739 +15,569	+128%	+$239K	﹤0.01%	3848
2021 Q1	$213K	Sell	12,170 -1,702	-12%	-$30.3K	﹤0.01%	4033
2020 Q4	$183K	Sell	13,872 -607	-4%	-$8.57K	﹤0.01%	3996
2020 Q3	$157K	Sell	14,479 -539	-4%	-$6.94K	﹤0.01%	3898
2020 Q2	$186K	Buy	+15,018	New	+$203K	﹤0.01%	3809

Other funds holding XGN

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GWN Securities Palm Beach Gardens, Florida $598M AUM 32.4% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return

R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Bank of New York Mellon's XGN Position: Q2 2026 in Review

Bank of New York Mellon held its Exagen (XGN) position steady in Q2 2026 at 20,938 shares worth $97.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4199.

Bank of New York Mellon first reported a position in XGN in Q2 2020 and has held it in 12 quarters since. The position peaked at $435K in Q3 2021. 14 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Bank of New York Mellon held 20,938 shares of Exagen worth $97.4K as of Q2 2026.
Bank of New York Mellon left its Exagen share count unchanged in Q2 2026.
Exagen made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4199 holding.
Bank of New York Mellon first reported a position in Exagen in Q2 2020 and has held it in 12 quarters since.
Bank of New York Mellon's Exagen position peaked at $435K in Q3 2021.
14 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.